ArticlePharmaceutics2019

Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines.

Arianna Bonizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.